Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mixed Chimerism for Inherited Metabolic Disorders
NCT01372228Phase 2Terminated
- Sponsor
- Talaris Therapeutics
- Start
- Apr 2011
- Primary completion
- Apr 2016
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
- Countries
- 1
01
Overview
A Phase 2 trial of FCR001 in Hurler syndrome, Hurler-Scheie syndrome, mucopolysaccharidosis type II, Sanfilippo syndrome, Krabbe disease, sponsored by Talaris Therapeutics. Started Apr 2011; status: terminated.
02
Drugs
FCR001
03
Conditions
Hurler syndromeHurler-Scheie syndromemucopolysaccharidosis type IISanfilippo syndromeKrabbe disease
Beyond the preview
Go deeper on NCT01372228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01372228.